Market goliaths in the news - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Market goliaths in the news

Jun 9, 2001

The bourses continued the declining trend as unwinding of positions loomed large. The BSE Sensex and NSE Nifty declined by 62 points (1.7%) and 22 points (1.9%) respectively during the week. Although the NASDAQ closed lower on the last trading day of the week on fresh rounds of corporate warnings, the index closed the week higher by 3%. Juniper Networks, the leading networking equipment company, was the latest victim of the U.S economic downturn. The company warned that earnings for the current quarter could come in as much as 66% below forecasts.

Mid-week sentiments for the semi-conductor industry were pepped-up with industry proxy, Intel, issuing a statement that second quarter results will be within the estimated range, however, on the lower end of the band. During the first quarter result announcement the company gave revenue guidance of $6.2 bn - $6.8 bn for the second quarter. The clincher, however, really was the company's belief that the microprocessor business seems to be stabilizing.

Back home another industry behemoth, HLL, is facing some unfavourable treatment on the bourses. The scrip has fallen by 6.8% over the last two trading weeks. It also dipped below the psychological barrier of Rs 200 after almost 4 months. The scrip over the past six months had recovered from its 52-week lows touched in October '00, especially after announcing favourable results for FY00. However, 1QFY01 topline grew by meager 1.1%, which once again put doubt in the minds of participants regarding growth prospects of the company.

Fears, currently, do not seem to be unfounded. Latest industry reports do not paint a pretty picture for the company. According to reports, April retail sales of the company have shown a decline of 4.7% YoY during the month. While in March 2001, the retail sales slid by 2.4% YoY. Also, reports reveal that the total FMCG market sales growth was a marginal 0.6% YoY for April and is the lowest since January 2000. Consequently, the picture does not look good for the entire sector. But that could be gauged with HLL itself not doing well as the company represents more than 50% of the organized FMCG market. The company faces a daunting task ahead if topline growth for 2QFY01 is to be re-invigorated.

Pharma stocks were also in the thick of things over the past week. Sector stalwart Glaxo fell heavily to touch a new 52-week low. In fact, both Glaxo and Smithkline Pharma have been declining since the company's analyst meet, which outlined grim market conditions for its products. The company's combined turnover is down by about 20% in April-May 2001 YoY. As a result, institutions seem to be trimming their positions in the stock. However, bargain hunters picked up the stock at the lower levels on Friday.

On the other hand Dr. Reddy's continued to hold strong through the week. The company had a good run in FY01. It has recently announced out-licensing of its diabetes molecule to Novartis. The company would receive US$ 55 m in up front and milestone earnings. The U.S court ruling in favour of Barr Labs for launch of fluoxetine 10 mg / 20 mg (generic Prozac, a blockbuster anti-depressant drug) has come as a blessing in disguise for Dr. Reddy’s. The company has a similar case for the same drug in 40 mg dosage. One can expect a similar decision resulting in 180 days marketing exclusivity for its generic product. The potential for Dr. Reddy’s is huge given that the annual branded sales for fluoxetine are in the range of US $ 275 m.

Net outstanding positions on the BSE have declined to Rs 6.5 bn from Rs 8.3 bn in the previous week. There continues to remain absence of any local drivers. NASDAQ closed lower on last Friday and the domestic tech counters could feel the reverberations.


Equitymaster requests your view! Post a comment on "Market goliaths in the news". Click here!

  

More Views on News

How Much Money Should an Investor Set Aside for Trading? (Fast Profits Daily)

Sep 21, 2020

In this video, I'll give you a simple equation which you can use to decide how much money you can set aside for trading.

Kotak Standard Multicap Fund: Strategizing Growth with Focused Approach (Outside View)

Sep 21, 2020

PersonalFN's analysis on the features and performance of Kotak Standard Multicap Fund.

Sensex Can Go to 25,000 Before it Goes to 60,000. Are You Prepared? (Profit Hunter)

Sep 21, 2020

Am I expecting a big crack in the Sensex and what next?

What Do the Charts Say About Buying Smallcaps Now? (Fast Profits Daily)

Sep 18, 2020

Everyone seems to be excited about buying smallcaps now...but is it the right thing to do? What do the charts tell us? Find out in this video...

Sundaram Bluechip Fund: Will Hold the Stable Horses (Outside View)

Sep 18, 2020

PersonalFn briefly outlines the newly launched NFO note HSBC Corporate Bond Fund.

More Views on News

Most Popular

How the 8-Year Cycle Can Help Identify Multibaggers (Fast Profits Daily)

Sep 11, 2020

This is how you can apply the greed and fear cycle in the market to pick stocks.

Why am I Recommending Caution? (Fast Profits Daily)

Sep 9, 2020

This is why I have changed my short-term view on the market.

This Could Be the Best September for Auto Stocks (Profit Hunter)

Sep 11, 2020

Here's why I think this month could be a great for auto stocks.

Why We Picked This Small-cap Stock for Our Hidden Treasure Subscribers (Profit Hunter)

Sep 17, 2020

This leading household brand will profit big time in a post covid world.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE SENSEX


Sep 21, 2020 03:35 PM

MARKET STATS